Quality assurance in cells power plants
Tyynismaa's group studied a mitochondrial enzyme, which attaches the correct amino acid to the transfer RNA, which directs protein synthesis. Working together with the Chinese Academy of Sciences and University of Turku researchers, the group established that this enzyme makes mistakes and can attach the wrong amino acids to the transfer RNA. This means that the amino acid sequence in the resulting respiratory chain proteins would be incorrect, unless the enzyme had an additional mechanism to correct its mistakes.
"We found that the error-correction mechanism of this mitochondrial enzyme is vital for the cell: even a slight decrease in the correction mechanism had an adverse effect on the function of the cell. The significance of this mechanism for the mitochondria was previously unknown," explains Tyynismaa.
Deviations in the mitochondrial protein synthesis can result in many different hereditary diseases. The enzyme, which is the focus of this research, is also known to harbour disorders caused by genetic anomalies, which may result either in a severe neonatal heart disease or a brain disease with an onset in early adulthood.
"We do not currently know whether these diseases are the result of the weakened ability of the enzyme to attach the correct amino acids to the transfer RNA or problems in its error-correction mechanism. A better understanding of the enzyme's fundamental mechanisms may help us determine the impact of the faulty genes in the future," says Tyynismaa.
Original publication
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.